The pur­pose of the proof-of-con­cept study is to con­firm that our elec­tri­cal­ly con­duc­tive, ver­ti­cal­ly aligned car­bon nanofibers can func­tion as an inter­con­nect between an inte­grat­ed cir­cuit and a sen­sor mate­r­i­al that is not com­pat­i­ble with metals.

We have been col­lab­o­rat­ing with the glob­al medtech com­pa­ny for some time and a num­ber of ini­tial tests have already been per­formed. How­ev­er, the cur­rent proof-of-con­cept study will include a more com­plete test of the con­cept, which among oth­er things aims to ver­i­fy the per­for­mance of the solu­tion and to ensure that the assem­bly lasts, as well as to obtain more knowl­edge in how to scale up the con­cept to vol­ume production.

“This is a great busi­ness oppor­tu­ni­ty for us, in a unique con­text where we don’t real­ly see any alter­na­tive solu­tions. The medtech indus­try is very inter­est­ing as a poten­tial busi­ness area for Smoltek’s future expan­sion, in addi­tion to our two pri­or­i­ty busi­ness areas: the semi­con­duc­tor indus­try, where we devel­op ultra-thin capac­i­tors for appli­ca­tion proces­sors and the hydro­gen indus­try, where we devel­op high-per­for­mance cell mate­ri­als for electrolyzers”

says Smoltek’s CEO Håkan Persson

The car­bon nanofiber tech­nol­o­gy used in this proof-of-con­cept study is very sim­i­lar to what we are devel­op­ing for our main busi­ness track – ultra-thin capac­i­tors, and the study is an excel­lent exam­ple of the many areas where the company’s tech­nol­o­gy can be applied.

The order to car­ry out the proof-of-con­cept study is worth 40,000 euros.